Merav Heshin-Bekenstein
Overview
Explore the profile of Merav Heshin-Bekenstein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
133
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Toor K, Chen A, Cabral D, Mammen C, Bosman E, Shen Y, et al.
Arthritis Rheumatol
. 2024 Dec;
PMID: 39624015
Objective: We aimed to study the disease course, outcomes, and predictors of outcome in pediatric-onset antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) affecting the kidneys. Methods: Patients eligible for this study...
2.
Eviatar T, Ziv A, Oved A, Miller-Barmak A, Pappo A, Livny R, et al.
Vaccine
. 2024 Oct;
42(26):126426.
PMID: 39423454
This prospective, longitudinal, multicenter study assessed the safety and efficacy of the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine among children 4-11 years-old with autoimmune inflammatory rheumatologic disease (AIIRD), compared to healthy...
3.
Baldo F, Erkens R, Mizuta M, Rogani G, Lucioni F, Bracaglia C, et al.
Rheumatology (Oxford)
. 2024 Jul;
64(1):32-44.
PMID: 39058514
Objective: To assess current treatment in macrophage activation syndrome (MAS) worldwide and to highlight any areas of major heterogeneity of practice. Methods: A systematic literature search was performed in both...
4.
Eviatar T, Pappo A, Freund T, Friedlander Y, Elkayam O, Hagin D, et al.
Clin Exp Immunol
. 2024 May;
217(2):167-172.
PMID: 38767466
This paper aims to compare the cellular immune response to the SARS-CoV-2 BNT162b2 vaccine of pediatric patients with autoimmune inflammatory rheumatic disease (pAIIRD) and healthy controls. A prospective longitudinal study...
5.
Maritsi D, Dasoula F, Ziv A, Bizjak M, Balaziova B, Matosevic M, et al.
Eur J Pediatr
. 2024 Apr;
183(7):2937-2944.
PMID: 38619568
While most countries provide safe and effective influenza vaccines for at-risk groups, influenza vaccine coverage among children with rheumatic diseases remains uncertain. This study investigated influenza vaccination rates in children...
6.
Kaya Akca U, Batu E, Jelusic M, Calatroni M, Bakry R, Frkovic M, et al.
Rheumatology (Oxford)
. 2023 Dec;
63(SI2):SI122-SI128.
PMID: 38135503
Objective: Granulomatosis with polyangiitis (GPA) is an ANCA-associated vasculitis. The 2022 ACR/EULAR-endorsed classification criteria for GPA was derived using data only from adult patients. We aimed to assess the performance...
7.
Heshin-Bekenstein M, Baron S, Schulert G, Shusterman A, Fidel V, Ben-Shahar Y, et al.
Arthritis Res Ther
. 2023 Jul;
25(1):135.
PMID: 37525216
Background: Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease in children, causing significant morbidity. Despite the dramatic improvement in treatment, many patients do not achieve complete remission,...
8.
Sestan M, Kifer N, Sozeri B, Demir F, Ulu K, Silva C, et al.
Semin Arthritis Rheum
. 2023 May;
61:152209.
PMID: 37126983
Objective: IgA vasculitis (IgAV) (formerly Henoch-Schönlein Purpura, HSP) rarely causes severe skin lesions in children. The purpose of the research was to determine whether severe skin manifestations were associated with...
9.
Heshin-Bekenstein M, Ziv A, Toplak N, Lazauskas S, Kadishevich D, Ben-Nun Yaari E, et al.
Vaccines (Basel)
. 2023 Apr;
11(4).
PMID: 37112731
Background: To explore the long-term safety and dynamics of the immune response induced by the second and third doses of the BNT162b2 mRNA COVID-19 vaccine in adolescents with juvenile-onset autoimmune...
10.
Bizjak M, Heshin-Bekenstein M, Jansen M, Ziv A, Angevare S, Uziel Y, et al.
Front Pediatr
. 2023 Jan;
10:1098332.
PMID: 36704144
With the introduction of biological disease-modifying antirheumatic drugs (bDMARDs), the treatment of pediatric patients with autoimmune/inflammatory rheumatic diseases (pedAIIRD) has advanced from the "Stone Age" to modern times, resulting in...